Spyros Garbis1, Gert Lubec, Michael Fountoulakis
1Academy of Athens, Foundation for Biomedical Research, Division of Biotechnology, Soranou Ephessius 4, 11527 Athens, Greece.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Proteomics aids in understanding disease mechanisms and finding drug targets. However, current proteomics technologies have limitations, particularly in brain investigations, which this article addresses.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: